Abstract:OBJECTIVE:To establish a simple, rapid and easy method for screening the gene mutation in hemophilia A, which was further applied to a direct diagnosis and carrier detection at gene level.METHODS:Twenty-four clinically diagnosed hemophilia pedigrees, including all the hemophilia patients and female members, were tested for the introns 22 and 1 in factor VIII gene by using inversion polymerase chain reaction (PCR) and regular PCR techniques. All the 26 exons of factor VIII gene were consecutively screened in the 17 patients manifesting non-inverted sequences in intron 22 by using PCR, subsequently all the 37 amplicons resulted from 26 exons were analyzed by conformation sensitive gel electrophoresis (CSGE), finally the mutated exons were subjected to sequencing verification. According to the mutation results, mothers and twin sisters of the hemophilia probands were tested by CSGE or subjected to nucleotide sequencing directly, to ascertain if those individuals had the same mutation or were the carriers of disease-causing gene.RESULTS:Intron 22 inversion was detected in 7 hemophilia probands out of 24 hemophilia pedigrees, intron 1 inversion was not detected in these pedigrees. Single-base mutations distributed in different exons of factor VIII gene were detected in 13 pedigrees with family history and 3 sporadic pedigrees, diagnosed as non-inverted 22 intron patients. By comprehensive usage of PCR-CSGE and nucleotide sequencing, the positive rate and the diagnosable rate of gene diagnosis or carrier detection in the 24 hemophilia pedigrees was 94.12% and 100% respectively.CONCLUSION:PCR-CSGE is a highly sensitive and special assay for detecting single base mutation. By integrated utilization of introns 22 and 1 of factor VIII gene detection and PCR-CSGE genotyping, combining with nucleotide sequencing, a direct diagnosis of all hemophilia pedigrees be could nearly make at gene level, including the sporadic families. This method might be used to screen new mutation theoretically and ascertain the mutation type. It is a simple, rapid and low-cost method, possessing unique advantages in direct diagnosis of hemophilia A and carrier screening. It should have important application value in hemophilia diagnosis.

Direct Sequencing in Hemophilia A Carrier Diagnosis and Prenatal Diagnosis

Carrier detection and prenatal diagnosis of haemophilia

Carrier Detection and Prenatal Diagnosis of Hemophilia A.

Gene diagnosis of co-existed hemophilia A and B in a pedigree

The status of carrier and prenatal diagnosis of haemophilia in China.

Genetic Counseling in Two Particular Hemophilia A Families

[Application Studies on the Gene Diagnosis and Carrier Detection of Hemophilia A by Using Polymerase Chain Reaction-Conformation Sensitive Gel Electrophoresis].

Genetic diagnosis of hemophilia A families with no proband

Detection of FⅧ Gene Intron 22 and 1 Inversion Using Inversion-PCR Assay in Hemophilia A

Studies on the Molecular Mechanisms of Large Deletion in the F8 Gene in a Severe Haemophilia A Patient

[Mutation screening of the F VIII gene in 10 hemophilia A families].

Application of indirect linkage analysis and direct genotyping to hemophilia A carrier detection in Sichuan, China.

Haemophilia A in a female with a novel INV22 mutation and skewed X-chromosome inactivation

Characterization of Genetic Defects in Casese of Haemophilia A of Chinese Origin

A female haemophilia caused by FⅧ gene intron 1 inversion and non-random inactivation of X-chromosome

Single Cell Four-Plex Nested Fluorescent PCR for Hemophilia A Genetic Diagnosis and Gender Determination

Molecular pathogenesis of two novel splice site mutations of F8 in hemophilia A

Detection of Factor Ⅸ gene Mutation in Paitients with Hemophilia B by DNA Sequencing

An Intronic Mutation C.6430-3C>g in the F8 Gene Causes Splicing Efficiency and Premature Termination in Hemophilia A

Polymorphism of intron13(CA)n repeat within FⅧ gene in hemophilia A children and kindred

Study on Intron 22 Inversion with the Patients of Hemophilia A